You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Serious Game for Continuity of Care Training
SBC: VCOM3D INC Topic: OSD10H08For this Phase II SBIR project, Vcom3D proposes a Serious Game for Continuity of Care that trains combat physicians in making critical medical decisions when faced with a multiple-casualty, multi-trauma incident. The Serious Game for Continuity of Care will provide a fast-paced learning environment that will require the selective attention to numerous, competing visual and aural cues and delegatio ...
SBIR Phase II 2013 Department of DefenseDefense Health Agency -
Development of a field-appropriate biosensor for detecting Mycobacterium tuberculosis infection
SBC: NANORETE, INC. Topic: OSD11H05nanoRETE is a developing a nanoparticle-based biosensor technology platform that has the ability for real-time detection of pathogens. Tuberculosis (TB) is a disease caused by Mycobacterium tuberculosis (Mtb) that primarily affects the lungs. In Phase I research, nanoRETE demonstrated proof-of-concept of an electrochemical nano-bead biosensor for measuring plasma cytokine and chemokine concentrati ...
SBIR Phase II 2013 Department of DefenseDefense Health Agency -
A rapid and high-throughput microfluidic stem cell analyzer
SBC: CFD RESEARCH CORPORATION Topic: OSD11H14Current methods to discern the differentiation state of stem cells are time-consuming, labor-intensive, costly, invasive, and consequently, ill-suited for clinical applications. To overcome these limitations, we propose to develop a microfluidic stem cell analyzer for accurate, non-invasive identification of the cell differentiation state in conjunction with automated cell sorting at high-throughp ...
SBIR Phase II 2013 Department of DefenseDefense Health Agency -
Monitoring Metabolic Energy Expenditure Via the Prosthetics of Lower Extremity Amputees
SBC: BARRON ASSOCIATES, INC. Topic: OSD11H07Limb loss affects approximately 1.9 million people in the United States. It is well established that lower-limb amputees show greater metabolic demands during gait and more limited mobility compared to non-disabled individuals. Currently, there is no lower-extremity prosthesis available that can monitor the metabolic costs of the amputee. The proposed solution, code-named TEQUILA (Total Energy exp ...
SBIR Phase II 2013 Department of DefenseDefense Health Agency -
Environment, Epidemiology, and Etiology Surveillance and Analysis Toolkit (E3SAT)
SBC: KNOWLEDGE BASED SYSTEMS INC Topic: OSD08H07The goal of the Environment, Epidemiology, and Etiology Surveillance and Analysis Toolkit (E3SAT) project is to develop a data analysis infrastructure, models and templates to facilitate environmental, epidemiological and etiological analysis. E3SAT provides a research data cube and analysis tool suite that allows researchers to collect, integrate and data mine medical information, environmental ...
SBIR Phase II 2013 Department of DefenseDefense Health Agency -
SynDaver Synthetic Human Phase Two
SBC: SYNDAVER LABS INC. Topic: OSD10H09This project is divided into a refinement phase and an optional advanced technologies phase. The first year will be devoted to development of a simplified SynDaver Basic (SB) model, a more advanced male full body (SSH-MFB) version of the SynDaver Synthetic Human, and simple sensing technologies to allow the SSH to be used in armor and MRAP development. The second year will focus on development ...
SBIR Phase II 2013 Department of DefenseDefense Health Agency -
A Nano-pharmaceutical Platform for Creating Artificial Vaccines
SBC: PARABON NANOLABS, INC. Topic: OSD11H01In this project, Parabon NanoLabs will employ its Essemblix(tm) Drug Development Platform, a combination of computer-aided design (CAD) software and DNA nano-fabrication technology, to produce artificial vaccines against the biothreat agent ricin on DNA origami decorated first with natural epitopes and ultimately with artificial epitotopes (hereafter"mimotope") constructed from a predefined set of ...
SBIR Phase II 2013 Department of DefenseDefense Health Agency -
Biological Activity Assay and Bioanalytical Test Method Development for a Silk-Derived Protein (SDP) Eye Drop Product
SBC: SILK TECHNOLOGIES, LTD. Topic: NonDoDThe company has developed a silk-derived protein (SDP) for use as a novel ophthalmic formulation excipient that will help to treat the ocular injuries and dry eye pathology that affects over 40 million Americans annually and hundreds of millions of people worldwide. The SDP excipient is designed to enhance tear formulation comfort, longevity, and overall ocular health. This proposal builds on the ...
SBIR Phase II 2019 Department of DefenseDefense Health Agency -
Electrochemical Drug Infusion Pump
SBC: LYNNTECH INC. Topic: OSD05H01The CONOPS for the Expeditionary Medical Support System (EMEDS) is based on practical effectiveness, speed, and efficiency. Key among the tools required by the Air Mobility Command and the Air Combat Command, which are two of the major commands that are part of the United Air Force is a multi-channel intravenous infusion pump capable of delivering fluids that meets the safe-to-fly criteria for all ...
SBIR Phase II 2019 Department of DefenseDefense Health Agency -
Selective Aortic Arch Perfusion Technologies for Hemorrhage-induced Cardiac Arrest
SBC: Hays, Inc. Topic: DHP16009Thereis increased interest in endovascular hemorrhagecontrol using aortic balloon occlusion to improve outcomes in preventable battlefield death from non-compressibletorso hemorrhage(NCTH). Our technology, the SABOT, is the nextgeneration in such catheters,which adds the ability of both selectivevascular bed perfusion, bypassinginjured beds, and partial perfusion. In phaseI thefeasibility and proo ...
SBIR Phase II 2018 Department of DefenseDefense Health Agency